Characterized tissue with pathological grading and blood samples as well as other biofluidsforms the basis for all biobanks as a resource in modern life science. Biobanks are accessed tomeasure biological components that can be used to monitor the status of health and diseasein individual samples and population groups. The biomarker diagnostics area, predictingdrug efficacy, stratification of patient groups, can benefit from the continuous qualitativedevelopments, where Proteomics can make a difference in lung cancer and COPD. This inturn can provide key treasures to novel drugs for personalized medicine in the future.
- Lung cancer
ASJC Scopus subject areas